Overview

Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain

Status:
Completed
Trial end date:
2001-04-01
Target enrollment:
Participant gender:
Summary
Once patients' postoperative pain intensity reaches a moderate-to-severe level, they are randomized to receive intranasal ketamine or placebo. Patients remain in the study unit for 3 hours post administration and assess pain intensity and pain relief throughout the 3 hour postoperative period.
Phase:
Phase 2
Details
Lead Sponsor:
Javelin Pharmaceuticals
Treatments:
Ketamine